Approvals/TGA/SANDOSTATIN LAR octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack

Approved

STANDARD

SANDOSTATIN LAR octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack

Approval Id: b329015efdd02f93
Product Name: SANDOSTATIN LAR octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack
Artg Id: 227964
Artg Name: SANDOSTATIN LAR octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2015-03-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/015e5a25df85af4ddb78e35674619d8d.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a558a04ebcb5ed07822ab38a9f5948ce.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b329015efdd02f93

Type

Standard